www.grandviewresearch.com
Growing demand for diagnostic imaging processes is one of the major divers for the growth of medical imaging reagents market. Medical imaging reagents play a vital role in pharmaceuticals, diagnostic, biotechnology life science and medical industries. These reagents are specially designed to enhance images quality formed through imaging systems. Growing prevalence of chronic diseases such as cancer, neurovascular diseases and cardiovascular diseases and rising geriatric population base are some other drivers expected to fuel the growth this market during the forecast period.
Optical reagents, contrast reagents, and nuclear reagents are the product segments of medical imaging reagents market. Nuclear reagents market is anticipated to witness a fruitful CAGR in the coming six years due to its efficient application for carrying out immunoassays and protein interaction studies. Technology based medical imaging reagent market includes radiopharmaceuticals, nanoparticles, fluorescent dyes & probes and quantum dots. Radiopharmaceuticals segment is anticipated to grow at the highest CAGR owing to increasing awareness about radioisotopes and rising patient preference.
North America held the largest market revenue share in 2013 over 40% followed by Europe. Presence of sophisticated healthcare infrastructure and growing number of government initiatives working towards reducing healthcare expenditure are the drivers contributing for its highest share.
Some key market players reported in this report are Bayer Healthcare AG, GE Healthcare, Mallinckrodt Pharmaceuticals, Thermo Fisher Inc., Lantheus Medical Imaging, Bracco Imaging SpA, Siemens Healthcare and others.



Recent comments
Finally a classy storage
This is a great cause to
This is certainly an
how many module I can Found
Thank You, TurtleDog! I'm
Weatherproof Electrical Box
This a great scoop. Cameras
I think it's wise for an
Funny, I'm the same way. I
Hmmmm, interesting. I didn't